PreciControl HBsAg II - Hepatitis B virus surface antigen IVD, control

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Roche Diagnostics Australia Pty Limited

clase:

Class 4

Fabricado por:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Área terapéutica:

42000 - Hepatitis B virus surface antigen IVD, control

indicaciones terapéuticas:

A ready to use control serum based on human serum both in the negative and positive concentration range. For quality control of the Elecsys HBsAg II and Elecsys HBsAg II Auto Confirm immunoassays on the Elecsys and cobas e immunoassay analysers.

Estado de Autorización:

A

Fecha de autorización:

2013-09-13